International network of cancer genome projects

Nature

Volumn 464, Issue 7291, 2010, Pages 993-998

  Hudson, Thomas J ^a,b   Anderson, Warwick ^c   Aretz, Axel ^d   Barker, Anna D ^e   Bell, Cindy ^f   Bernabé, Rosa R ^g   Bhan, M K ^h   Calvo, Fabien ⁱ   Eerola, Iiro ^j   Gerhard, Daniela S ^e   Guttmacher, Alan ^k   Guyer, Mark ^l   Hemsley, Fiona M ^m   Jennings, Jennifer L ^a   Kerr, David ^n,o   Klatt, Peter ^g   Kolar, Patrik ^j   Kusuda, Jun ^p   Lane, David P ^m   Laplace, Frank ^q   Lu, Youyong ^r   Nettekoven, Gerd ^s   Ozenberger, Brad ^l   Peterson, Jane ^l   Rao, T S ^h,h   Remacle, Jacques ^j   Schafer, Alan J ^t   Shibata, Tatsuhiro ^u   Stratton, Michael R ^v   Vockley, Joseph G ^e   Watanabe, Koichi ^w   Yang, Huanming ^x   Yuen, Matthew M F ^y   Knoppers, Bartha M ^z   Bobrow, Martin ^aa   Cambon Thomsen, Anne ^ab   Dressler, Lynn G ^ac   Dyke, Stephanie O M ^v   Joly, Yann ^z   Kato, Kazuto ^ad   Kennedy, Karen L ^v   Nicolás, Pilar ^ae   Parker, Michael J ^af   Rial Sebbag, Emmanuelle ^ab   Romeo Casabona, Carlos M ^ae   Shaw, Kenna M ^e   Wallace, Susan ^z   Wiesner, Georgia L ^ag,ah   Zeps, Nikolajs ^ai,aj   Lichter, Peter ^ak   Biankin, Andrew V ^al,am   Chabannon, Christian ^i,an   Chin, Lynda ^ao,ap   Clément, Bruno ^ab   Alava, Enrique De ^aq   Degos, Françoise ^ar   Ferguson, Martin L ^as   Geary, Peter ^at   Hayes, D Neil ^au   Johns, Amber L ^al   Kasprzyk, Arek ^a   Nakagawa, Hidewaki ^av   Penny, Robert ^aw   Piris, Miguel A ^ax   Sarin, Rajiv ^ay   Scarpa, Aldo ^az,ba   De Vijver, Marc Van ^bb,bc   Futreal, P Andrew ^v   Aburatani, Hiroyuki ^bd   Bayés, Mónica ^be,bf   Bowtell, David D L ^bg,bh   Campbel, Peter J ^bi,dh   Estivill, Xavier ^be,bf   Grimmond, Sean M ^bj   Gut, Ivo ^bk   Hirst, Martin ^bl   López Otý́n, Carlos ^bm   Majumder, Partha ^bn   Marra, Marco ^bl   McPherson, John D ^a,bo   Ning, Zemin ^v   Puente, Xose S ^bm   Ruan, Yijun ^bp   Stunnenberg, Hendrik G ^bq   Swerdlow, Harold ^v   Velculescu, Victor E ^br   Wilson, Richard K ^bs,bt   Xue, Hong H ^y,bu   Yang, Liu ^bv   Spellman, Paul T ^bw   Bader, Gary D ^b,bo   Boutros, Paul C ^a   Flicek, Paul ^bg   Getz, Gad ^by   Guigó, Roderic ^be   Guo, Guangwu ^x   Haussler, David ^bz   Heath, Simon ^bk   Hubbard, Tim J ^v   Jiang, Tao ^x   Jones, Steven M ^bl   Li, Qibin ^x   López Bigas, Nuria ^ca   Luo, Ruibang ^x   Muthuswamy, Lakshmi ^a   Ouellette, B F Francis ^a   Pearson, John V ^bj   Quesada, Victor ^bm   Raphael, Benjamin J ^cb   Sander, Chris ^cc   Speed, Terence P ^cd,ce   Stein, Lincoln D ^a   Stuart, Joshua M ^bz   Teague, Jon W ^v   Totoki, Yasushi ^u   Tsunoda, Tatsuhiko ^av   Valencia, Alfonso ^ax   Wheeler, David A ^cf   Wu, Honglong ^x   Zhao, Shancen ^x   Zhou, Guangyu ^x   Lathrop, Mark ^bk,cg   Thomas, Gilles ^ch,ci   Yoshida, Teruhiko ^u   Axton, Myles ^cj   Gunter, Chris ^ck   Miller, Linda J ^cl   Zhang, Junjun ^a   Haider, Syed A ^cm   Wang, Jianxin ^a   Yung, Christina K ^a   Cross, Anthony ^a   Liang, Yong ^a   Gnaneshan, Saravanamuttu ^a   Guberman, Jonathan ^a   Hsu, Jack ^a   Chalmers, Don R C ^cn   Hasel, Karl W ^f   Kaan, Terry S H ^co   Lowrance, William W ^cp   Masui, Tohru ^p   Rodriguez, Laura Lyman ^l   Vergely, Catherine ^cq   Bowtel, David D L ^ba,bh   Cloonan, Nicole ^bj   DeFazio, Anna ^cr,cs   Eshleman, James R ^ct   Etemadmoghadam, Dariush ^bg,bh   Gardiner, Brooke A ^bj   Kench, James G ^al,cu   Sutherland, Robert L ^al   Tempero, Margaret A ^cv   Waddell, Nicola J ^bj   Wilson, Peter J ^bj   Gallinger, Steve ^cw,cx   Tsao, Ming Sound ^k,bo   Shaw, Patricia A ^cz   Petersen, Gloria M ^da   Mukhopadhyay, Debabrata ^db   DePinho, Ronald A ^ao,ap   Thayer, Sarah ^ap   Shazand, Kamran ^a   Beck, Timothy ^a   Sam, Michelle ^a   Timms, Lee ^a   Ballin, Vanessa ^a   Ji, Jiafu ^r   Zhang, Xiuqing ^x   Chen, Feng ^r   Hu, Xueda ^x   Yang, Qi ^x   Tian, Geng ^x   Zhang, Lianhai ^r   Xing, Xiaofang ^r   Li, Xianghong ^r   Zhu, Zhenggang ^dc   Yu, Yingyan ^dc   Yu, Jun ^dd   Tost, Jörg ^bk,cg   Brennan, Paul ^de   Holcatova, Ivana ^df   Zaridze, David ^dg   Brazma, Alvis ^bx   Egevad, Lars ^dh   Prokhortchouk, Egor ^di   Banks, Rosamonde Elizabeth ^dj   Uhlén, Mathias ^dk   Viksna, Juris ^dl   Ponten, Fredrik ^dm   Skryabin, Konstantin ^dn   Futrea, P Andrew ^dh   Birney, Ewan ^bx   Borg, Ake ^do   Børresen Dale, Anne Lise ^dp,dq   Caldas, Carlos ^dr   Foekens, John A ^ds   Martin, Sancha ^v   Reis Filho, Jorge S ^dt   Richardson, Andrea L ^ao,du   Sotiriou, Christos ^dv   Veer, Laura Van'T ^bb   Birnbaum, Daniel ^an   Blanche, Hélène ^cg   Boucher, Pascal ⁱ   Boyault, Sandrine ^dw   Masson Jacquemier, Jocelyne D ^an   Pauporté, Iris ⁱ   Pivot, Xavier ^dx   Vincent Salomon, Anne ^dy   Tabone, Eric ^dw   Theillet, Charles ^dz   Treilleux, Isabelle ^dw   Bioulac Sage, Paulette ^ea   Decaens, Thomas ^eb,ec   OiseDegos, Franc ^ar   Franco, Dominique ^ed   Gut, Marta ^cg   Samuel, Didier ^ab,ee   Zucman Rossi, Jessica ^ab   Eils, Roland ^ak,ef   Brors, Benedikt ^ak   Korbe, Jan O ^r,eg   Korshunov, Andrey ^eh   Landgraf, Pablo ^ei   Lehrach, Hans ^ej   Pfister, Stefan ^ak,eh   Radlwimmer, Bernhard ^ak   Reifenberger, Guido ^ek   Taylor, Michael D ^el   Kalle, Christof Von ^ak   Majumder, Partha P ^bn,cy   Pederzoli, Paolo ^ba   Lawlor, Rita T ^ba   Delledonne, Massimo ^az   Bardelli, Alberto ^em,en   Gress, Thomas ^eo   Klimstra, David ^cc   Zamboni, Giuseppe ^az   Nakamura, Yusuke ^av,ep   Miyano, Satoru ^ep   Fujimoto, Akihiro ^av   Campo, Elias ^eq   Sanjosé, Silvia De ^er   Montserrat, Emili ^eq   González Dý́az, Marcos ^aq   Jares, Pedro ^eq   Himmelbaue, Heinz ^be   Bea, Silvia ^eq   Aparicio, Samuel ^es   Easton, Douglas F ^et   Collins, Francis S ^eu   Compton, Carolyn C ^e   Lander, Eric S ^by   Burke, Wylie ^ev   Green, Anthony R ^ew   Hamilton, Stanley R ^ex   Kallioniemi, Olli P ^ey   Ley, Timothy J ^bs   Liu, Edison T ^bp   Wainwright, Brandon J ^bj   more..

^a ONTARIO INSTITUTE FOR CANCER RESEARCH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL   (Australia)

^d GERMAN AEROSPACE CENTER DLR   (Germany)

^e NATIONAL CANCER INSTITUTE   (United States)

^f Genome Canada   (Canada)

^g Ministry of Science and Innovation   (Spain)

^h DEPARTMENT OF BIOTECHNOLOGY   (India)

ⁱ INSTITUT NATIONAL DU CANCER   (France)

^j EUROPEAN COMMISSION   (Belgium)

^k EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^l NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^m IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

ⁿ SIDRA MEDICAL AND RESEARCH CENTER   (Qatar)

^o UNIVERSITY OF OXFORD   (United Kingdom)

^p NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^q Federal Ministry of Education and Research   (Germany)

^r PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^s German Cancer Aid   (Germany)

^t WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^u NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^v WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^w RIKEN YOKOHAMA INSTITUTE   (Japan)

^x BGI SHENZHEN   (China)

^y HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^z MCGILL UNIVERSITY   (Canada)

^aa UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ab INSERM   (France)

^ac University of North Carolina   (United States)

^ad KYOTO UNIVERSITY   (Japan)

^ae UNIVERSITY OF DEUSTO   (Spain)

^af UNIVERSITY OF OXFORD   (United Kingdom)

^ag CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ah UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^ai ST JOHN OF GOD HOSPITAL   (Australia)

^aj UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^ak GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^al UNIVERSITY OF NEW SOUTH WALES   (Australia)

^am BANKSTOWN LIDCOMBE HOSPITAL   (Australia)

^an INSTITUT PAOLI CALMETTES   (France)

^ao DANA FARBER CANCER INSTITUTE   (United States)

^ap HARVARD MEDICAL SCHOOL   (United States)

^aq HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^ar BEAUJON HOSPITAL   (France)

^as MLF Consulting   (United States)

^at Canadian Tumour Repository Network   (Canada)

^au UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^av RIKEN   (Japan)

^aw International Genomics Consortium   (United States)

^ax Centro Nacional de Investigaciones Oncológicas   (Spain)

^ay TATA MEMORIAL HOSPITAL   (India)

^az UNIVERSITY OF VERONA   (Italy)

^ba UNIVERSITY HOSPITAL OF VERONA   (Italy)

^bb NETHERLANDS CANCER INSTITUTE   (Netherlands)

^bc ACADEMIC MEDICAL CENTER   (Netherlands)

^bd UNIVERSITY OF TOKYO   (Japan)

^be CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^bf CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^bg PETER MACCALLUM CANCER CENTRE   (Australia)

^bh UNIVERSITY OF MELBOURNE   (Australia)

^bi UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^bj UNIVERSITY OF QUEENSLAND   (Australia)

^bk DIF   (France)

^bl BRITISH COLUMBIA CANCER AGENCY   (Canada)

^bm UNIVERSITY OF OVIEDO   (Spain)

^bn NATIONAL INSTITUTE OF BIOMEDICAL GENOMICS   (India)

^bo UNIVERSITY OF TORONTO   (Canada)

^bp GENOME INSTITUTE OF SINGAPORE   (Singapore)

^bq RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^br JOHNS HOPKINS UNIVERSITY   (United States)

^bs WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^bt USA   (United States)

^bu HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^bv ZHEJIANG UNIVERSITY   (China)

^bw LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^bx EUROPEAN BIOINFORMATICS INSTITUTE   (United Kingdom)

^by MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^bz University of California Santa Cruz   (United States)

^ca UNIVERSITAT POMPEU FABRA   (Spain)

^cb Brown Univerity   (United States)

^cc MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^cd WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^ce UNIVERSITY OF CALIFORNIA   (United States)

^cf BAYLOR COLLEGE OF MEDICINE   (United States)

^cg FONDATION JEAN DAUSSET CEPH   (France)

^ch UNIVERSITÉ LYON 1   (France)

^ci Fondation Synergie Lyon Cancer   (France)

^cj Nature Genetics   (United States)

^ck HUDSONALPHA INSTITUTE FOR BIOTECHNOLOGY   (United States)

^cl Nature and the Nature Research Journals   (United States)

^cm UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^cn UNIVERSITY OF TASMANIA   (Australia)

^co NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^cp University of California San Francisco ^*  (France)

^cq INSTITUT GUSTAVE ROUSSY   (France)

^cr WESTMEAD HOSPITAL   (Australia)

^cs UNIVERSITY OF SYDNEY   (Australia)

^ct DEPARTMENT OF PATHOLOGY   (United States)

^cu ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^cv UNIVERSITY OF CALIFORNIA   (United States)

^cw TORONTO GENERAL HOSPITAL   (Canada)

^cx MOUNT SINAI HOSPITAL   (Canada)

^cy PRINCESS MARGARET HOSPITAL   (Canada)

^cz UNIVERSITY HEALTH NETWORK   (Canada)

^da MAYO CLINIC   (United States)

^db MAYO GRADUATE SCHOOL   (United States)

^dc SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^dd CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^de INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^df CHARLES UNIVERSITY   (Czech Republic)

^dg N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^dh KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^di INSTITUTE OF BIOENGINEERING   (Russian Federation)

^dj ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^dk ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

^dl UNIVERSITY OF LATVIA   (Latvia)

^dm UPPSALA UNIVERSITY   (Sweden)

^dn Kurchatov Scientific Center   (Russian Federation)

^do LUND UNIVERSITY   (Sweden)

^dp OSLO UNIVERSITY HOSPITAL   (Norway)

^dq UNIVERSITY OF OSLO   (Norway)

^dr UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ds JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

^dt INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^du BRIGHAM AND WOMEN S HOSPITAL   (United States)

^dv JULES BORDET INSTITUTE   (Belgium)

^dw CENTRE LÉON BÉRARD   (France)

^dx UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

^dy INSTITUT CURIE   (France)

^dz CENTRE VAL D AURELLE   (France)

^ea HÔPITAL PELLEGRIN   (France)

^eb HENRI MONDOR HOSPITAL   (France)

^ec INSERM U955   (France)

^ed HÔPITAL ANTOINE BÉCLÈRE   (France)

^ee HÔPITAL PAUL BROUSSE   (France)

^ef UNIVERSITY OF HEIDELBERG   (Germany)

^eg EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^eh UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^ei UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^ej MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^ek HEINRICH HEINE UNIVERSITY   (Germany)

^el HOSPITAL FOR SICK CHILDREN   (Canada)

^em UNIVERSITY OF TURIN   (Italy)

^en FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^eo PHILIPPS UNIVERSITY MARBURG   (Germany)

^ep THE UNIVERSITY OF TOKYO   (Japan)

^eq UNIVERSITY OF BARCELONA   (Spain)

^er CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^es BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

^et UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^eu NATIONAL INSTITUTES OF HEALTH   (United States)

^ev UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^ew UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^ex UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^ey UNIVERSITY OF HELSINKI   (Finland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

METHYLTRANSFERASE; TRANSCRIPTOME;

CANCER; DISEASE CONTROL; DISEASE TREATMENT; GENOMICS; INTERNATIONAL COOPERATION; MUTATION; TUMOR;

AMINO ACID SUBSTITUTION; ANGIOGENESIS; CANCER GENETICS; CANCER INVASION; CANCER RESEARCH; CANCER THERAPY; DNA METHYLATION; EPIGENETICS; GENE DELETION; GENE INSERTION; GENE MUTATION; GENE REARRANGEMENT; GENOMICS; HUMAN; INTERNATIONAL COOPERATION; METASTASIS; METHYLATION; ONCOGENE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SOMATIC MUTATION; TUMOR GENE;

DATABASES, GENETIC; DNA METHYLATION; DNA MUTATIONAL ANALYSIS; GENES, NEOPLASM; GENETICS, MEDICAL; GENOME, HUMAN; GENOMICS; HUMANS; INTELLECTUAL PROPERTY; INTERNATIONAL COOPERATION; MUTATION; NEOPLASMS;

EID: 77951115122     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature08987     Document Type: Review

References (35)

1. Stratton, M. R., Campbell, P. J. & Futreal, P. A. The cancer genome. Nature 458, 719-724 (2009).
2. Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57-70 (2000).
3. Slamon, D. J. et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N. Engl. J. Med. 344, 783-792 (2001).
4. Druker, B. J. et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N. Engl. J. Med. 344, 1031-1037 (2001).
5. Druker, B. J. et al. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N. Engl. J. Med. 344, 1038-1042 (2001).
6. Pleasance, E. D. et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463, 184-190 (2010).
7. Pleasance, E. D. et al. A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 463, 191-196 (2010).
8. Greenman, C. et al. Patterns of somatic mutation in human cancer genomes. Nature 446, 153-158 (2007).
9. Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061-1068 (2008).
10. Ding, L. et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 455, 1069-1075 (2008).
11. Wood, L. D. et al. The genomic landscapes of human breast and colorectal cancers. Science 318, 1108-1113 (2007).
12. Jones, S. et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321, 1801-1806 (2008).
13. Parsons, D. W. et al. An integrated genomic analysis of human glioblastoma multiforme. Science 321, 1807-1812 (2008).
14. Samuels, Y. et al. High frequency of mutations of the PIK3CA gene in human cancers. Science 304, 554 (2004). (Pubitemid 38541907)
15. Davies, H. et al. Mutations of the BRAF gene in human cancer. Nature 417, 949-954 (2002).
16. van Haaften, G. et al. Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer. Nature Genet. 41, 521-523 (2009).
17. Dalgliesh, G. L. et al. Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes. Nature 463, 360-363 (2010).
18. Yan, H. et al. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360, 765-773 (2009).
19. Ley, T. J. et al. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 456, 66-72 (2008).
20. Mardis, E. R. et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N. Engl. J. Med. 361, 1058-1066 (2009).
21. Shah, S. P. et al. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 461, 809-813 (2009).
22. Stephens, P. J. et al. Complex landscapes of somatic rearrangement in human breast cancer genomes. Nature 462, 1005-1010 (2009).
23. Dickson, D. Wellcome funds cancer database. Nature 401, 729 (1999).
24. Collins, F. S. & Barker, A. D. Mapping the cancer genome. Pinpointing the genes involved in cancer will help chart a new course across the complex landscape of human malignancies. Sci. Am. 296, 50-57 (2007).
25. Mortazavi, A., Williams, B. A., McCue, K., Schaeffer, L. & Wold, B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nature Methods 5, 621-628 (2008).
26. Shah, S. P. et al. Mutation of FOXL2 in granulosa-cell tumors of the ovary. N. Engl. J. Med. 360, 2719-2729 (2009).
27. Haider, S. et al. BioMart Central Portal-unified access to biological data. Nucleic Acids Res. 37, W23-W27 (2009).
28. Hubbard, T. J. et al. Ensembl 2009. Nucleic Acids Res. 37, D690-D697 (2009).
29. Pruitt, K. D. et al. The consensus coding sequence (CCDS) project: identifying a common protein-coding gene set for the human and mouse genomes. Genome Res. 19, 1316-1323 (2009).
30. Sherry, S. T. et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 29, 308-311 (2001).
31. International HapMap Consortium. A second generation human haplotype map of over 3.1 million SNPs. Nature 449, 851-861 (2007).
32. Matthews, L. et al. Reactome knowledgebase of human biological pathways and processes. Nucleic Acids Res. 37, D619-D622 (2009).
33. Toronto International Data Release Workshop Authors. Prepublication data sharing. Nature 461, 168-170 (2009).
34. Jones, S. et al. Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science 324, 217 (2009).
35. Chin, L. & Gray, J. W. Translating insights from the cancer genome into clinical practice. Nature 452, 553-563 (2008).